Thymoma radiotherapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(One intermediate revision by one other user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{AM}} {{AAM}}
{{CMG}}; {{AE}} {{AM}} {{AAM}}
==Overview==
==Overview==
[[Radiotherapy]] is used in the treatment of unresectable thymoma. Radiotherapy may be used to decrease the size and improve resectability, before surgery is attempted.
* [[Radiotherapy]] is used in the treatment of unresectable thymoma.  
* Radiotherapy may be used to decrease the size and improve resectability, before surgery is attempted.
 
==Radiotherapy==
==Radiotherapy==
Radiotherapy is used in unresectable thymoma or incompletely resected invasive thymoma.
* Radiotherapy is used in unresectable thymoma or incompletely resected invasive thymoma.
The dose and fraction schemes of radiotherapy depend on the indication of the radiation and the completeness of surgical resection.<ref>{{Cite web  | last =  | first =  | title = https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf | url = https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf | publisher =  | date =  | accessdate = }}</ref>
* The dose and fraction schemes of radiotherapy depend on the indication of the radiation and the completeness of surgical resection.<ref>{{Cite web  | last =  | first =  | title = https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf | url = https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==
Line 13: Line 15:
[[Category:Rare diseases]]
[[Category:Rare diseases]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Hematology]]
[[Category:Immunology]]
[[Category:Surgery]]

Latest revision as of 20:59, 20 November 2018

Thymoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Thymoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Thymoma radiotherapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Thymoma radiotherapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Thymoma radiotherapy

CDC on Thymoma radiotherapy

Thymoma radiotherapy in the news

Blogs on Thymoma radiotherapy

Directions to Hospitals Treating Thymoma

Risk calculators and risk factors for Thymoma radiotherapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amr Marawan, M.D. [2] Ahmad Al Maradni, M.D. [3]

Overview

  • Radiotherapy is used in the treatment of unresectable thymoma.
  • Radiotherapy may be used to decrease the size and improve resectability, before surgery is attempted.

Radiotherapy

  • Radiotherapy is used in unresectable thymoma or incompletely resected invasive thymoma.
  • The dose and fraction schemes of radiotherapy depend on the indication of the radiation and the completeness of surgical resection.[1]

References

  1. "https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/thymic.pdf" (PDF). External link in |title= (help)